COMPASS Pathways plc (CMPS) 10-Year Financial Performance & Capital Metrics

CMPS • • Industrial / General

HealthcareHealthcare FacilitiesBehavioral & Mental Health ServicesMental Health Therapeutics

AboutCOMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.Show more

Revenue $0
EBITDA -$178M -30.2%
Net Income -$155M -30.9%
EPS (Diluted) -2.30 +0.9%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -81.55% -40.1%
ROIC -442.54% -69.4%
Debt/Equity 0.21 +42.1%
Interest Coverage -39.79 +36.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 89 (top 11%)

✗Weaknesses

✗Weak Piotroski F-Score: 1/9
✗Shares diluted 32.2% in last year
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-64.44%

EPS CAGR

10Y-

5Y-

3Y-

TTM-23.64%

ROCE

10Y Avg-65.08%

5Y Avg-55.3%

3Y Avg-63.83%

Latest-81.74%

Peer Comparison

Mental Health Therapeutics

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CMPSCOMPASS Pathways plc	701.88M	7.31	-3.18			-6.31%		0.21
ATAIAtai Beckley N.V	1.35B	3.71	-3.99	-1.91%	-51.09%	-96.43%		0.21
NEUPNeuphoria Therapeutics Inc.	22.05M	4.10	-17.83		-40.76%	-30.24%	100%	0.01

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-
Cost of Goods Sold+	0	63K	112.87K	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-
Gross Profit+	0	-63K	-112.87K	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-0.79%	1%	-	-	-
Operating Expenses+	10.54M	18.45M	51.68M	83.22M	110.4M	136.92M	178.21M
OpEx % of Revenue	-	-	-	-	-	-	-
Selling, General & Admin	3.59M	8.62M	28.03M	39.19M	45.35M	49.4M	59.17M
SG&A % of Revenue	-	-	-	-	-	-	-
Research & Development	8.92M	12.56M	23.37M	44.03M	65.05M	87.52M	119.04M
R&D % of Revenue	-	-	-	-	-	-	-
Other Operating Expenses	-2.68M	-2.73M	286.91K	0	0	0	0
Operating Income+	-12.5M	-21.18M	-51.79M	-83.22M	-110.4M	-136.92M	-178.21M
Operating Margin %	-	-	-	-	-	-	-
Operating Income Growth %	-	-0.69%	-1.45%	-0.61%	-0.33%	-0.24%	-0.3%
EBITDA+	-12.48M	-21.12M	-51.68M	-83.05M	-110.07M	-136.68M	-177.97M
EBITDA Margin %	-	-	-	-	-	-	-
EBITDA Growth %	-	-0.69%	-1.45%	-0.61%	-0.33%	-0.24%	-0.3%
D&A (Non-Cash Add-back)	22K	63K	112.87K	175K	330K	242K	233K
EBIT	-10.54M	-22.33M	-65.05M	-71.54M	-91.1M	-115.48M	-149.05M
Net Interest Income+	0	0	-	0	0	2.42M	3.79M
Interest Income	0	0	0	0	0	4.62M	8.27M
Interest Expense	0	0	0	0	0	2.2M	4.48M
Other Income/Expense	-716K	1.58M	-13.26M	11.68M	19.31M	19.23M	24.68M
Pretax Income+	-13.22M	-19.6M	-65.05M	-71.54M	-91.1M	-117.68M	-153.53M
Pretax Margin %	-	-	-	-	-	-	-
Income Tax+	0	15K	-4.25M	199K	408K	780K	1.59M
Effective Tax Rate %	1%	1%	0.93%	1%	1%	1.01%	1.01%
Net Income+	-13.22M	-19.61M	-60.8M	-71.74M	-91.5M	-118.46M	-155.12M
Net Margin %	-	-	-	-	-	-	-
Net Income Growth %	-	-0.48%	-2.1%	-0.18%	-0.28%	-0.29%	-0.31%
Net Income (Continuing)	-13.22M	-19.61M	-60.8M	-71.74M	-91.5M	-118.46M	-155.12M
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0
EPS (Diluted)+	-2.35	-0.90	-1.68	-1.79	-2.16	-2.32	-2.30
EPS Growth %	-	0.62%	-0.87%	-0.07%	-0.21%	-0.07%	0.01%
EPS (Basic)	-2.35	-0.90	-1.68	-1.79	-2.16	-2.32	-2.30
Diluted Shares Outstanding	5.62M	21.72M	35.93M	40M	42.44M	51.03M	67.48M
Basic Shares Outstanding	5.62M	21.72M	35.93M	40M	42.44M	51.03M	67.48M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	26.28M	32.17M	202.4M	295.3M	191.65M	261.3M	201.29M
Cash & Short-Term Investments	22.91M	24.97M	190.33M	273.24M	143.21M	220.2M	165.08M
Cash Only	22.91M	24.97M	190.33M	273.24M	143.21M	220.2M	165.08M
Short-Term Investments	0	0	0	0	0	0	0
Accounts Receivable	0	0	0	11.22M	15.62M	28.93M	21.82M
Days Sales Outstanding	-	-	-	-	-	-	-
Inventory	943K	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-
Other Current Assets	3.37M	6.99M	8.92M	2.31M	1.22M	2.33M	2.58M
Total Non-Current Assets+	108K	218K	1.05M	5.6M	5.64M	14.69M	12.38M
Property, Plant & Equipment	108K	218K	245K	4.09M	2.62M	4.73M	2.19M
Fixed Asset Turnover	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0
Long-Term Investments	0	0	529K	525K	469K	469K	469K
Other Non-Current Assets	0	0	278K	213K	327K	6.16M	5.94M
Total Assets+	26.39M	32.39M	203.46M	300.9M	197.29M	275.99M	213.67M
Asset Turnover	-	-	-	-	-	-	-
Asset Growth %	-	0.23%	5.28%	0.48%	-0.34%	0.4%	-0.23%
Total Current Liabilities+	1.85M	23.87M	6.89M	15.11M	15.6M	19.6M	34.02M
Accounts Payable	694K	1.32M	2.75M	2.56M	4.76M	5.89M	12.28M
Days Payables Outstanding	-	7.68K	8.88K	-	-	-	-
Short-Term Debt	0	21.09M	0	0	0	0	5.51M
Deferred Revenue (Current)	0	0	0	0	0	0	0
Other Current Liabilities	0	52K	656K	5.29M	6.19M	8.09M	9.24M
Current Ratio	14.24x	1.35x	29.36x	19.55x	12.29x	13.33x	5.92x
Quick Ratio	13.72x	1.35x	29.36x	19.55x	12.29x	13.33x	5.92x
Cash Conversion Cycle	-	-	-	-	-	-	-
Total Non-Current Liabilities+	38.91M	0	0	1.38M	418K	30.64M	24.95M
Long-Term Debt	0	0	0	0	0	28.76M	24.65M
Capital Lease Obligations	0	0	0	1.38M	418K	1.88M	303K
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	38.91M	0	0	0	0	0	0
Total Liabilities	40.75M	23.87M	6.89M	16.49M	16.01M	50.24M	58.97M
Total Debt+	0	21.09M	0	3.61M	1.93M	33.05M	32.19M
Net Debt	-22.91M	-3.88M	-190.33M	-269.63M	-141.28M	-187.15M	-132.89M
Debt / Equity	-	2.48x	-	0.01x	0.01x	0.15x	0.21x
Debt / EBITDA	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-	-62.12x	-39.79x
Total Equity+	-14.37M	8.52M	196.56M	284.41M	181.28M	225.74M	154.69M
Equity Growth %	-	1.59%	22.08%	0.45%	-0.36%	0.25%	-0.31%
Book Value per Share	-2.56	0.39	5.47	7.11	4.27	4.42	2.29
Total Shareholders' Equity	-14.37M	8.52M	196.56M	284.41M	181.28M	225.74M	154.69M
Common Stock	122K	111K	367K	435K	440K	635K	702K
Retained Earnings	-17.95M	-37.56M	-97.9M	-169.64M	-261.15M	-379.61M	-534.73M
Treasury Stock	-3.9M	0	0	0	0	0	0
Accumulated OCI	-435K	-98K	14.61M	8.84M	-16.87M	-16.93M	-16.19M
Minority Interest	0	0	0	0	0	0	0

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-9.8M	-17.81M	-41.38M	-67.75M	-105.45M	-97.38M	-119.19M
Operating CF Margin %	-	-	-	-	-	-	-
Operating CF Growth %	-	-0.82%	-1.32%	-0.64%	-0.56%	0.08%	-0.22%
Net Income	-13.22M	-19.61M	-60.33M	-71.74M	-91.5M	-118.46M	-155.12M
Depreciation & Amortization	22K	63K	112K	175K	330K	242K	233K
Stock-Based Compensation	1.42M	3.25M	17.98M	8.64M	13.12M	17.28M	19.52M
Deferred Taxes	0	0	-221K	22K	0	0	0
Other Non-Cash Items	2.68M	1.14M	1.99M	1.8M	3.27M	86K	4.46M
Working Capital Changes	-704K	-2.66M	-912K	-6.64M	-30.67M	3.48M	11.72M
Change in Receivables	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0
Change in Payables	-12K	580K	1.3M	-163K	2.5M	864K	6.59M
Cash from Investing+	-130K	-165K	-628K	-334K	-596K	-64K	0
Capital Expenditures	-130K	-165K	-131K	-334K	-596K	-66K	0
CapEx % of Revenue	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	2K	0
Cash from Financing+	32.96M	18.38M	194.16M	156.65M	1.04M	173.83M	63.82M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	32.96M	-55K	16K	1.85M	600K	-690K	37.6M
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	-9.93M	-17.98M	-41.51M	-68.08M	-106.05M	-97.44M	-119.19M
FCF Margin %	-	-	-	-	-	-	-
FCF Growth %	-	-0.81%	-1.31%	-0.64%	-0.56%	0.08%	-0.22%
FCF per Share	-1.77	-0.83	-1.16	-1.70	-2.50	-1.91	-1.77
FCF Conversion (FCF/Net Income)	0.74x	0.91x	0.68x	0.94x	1.15x	0.82x	0.77x
Interest Paid	0	0	0	0	0	1.25M	3.07M
Taxes Paid	0	0	0	0	0	2.44M	1.12M

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-230.24%	-59.3%	-29.83%	-39.3%	-58.21%	-81.55%
Return on Invested Capital (ROIC)	-	-342.26%	-714.38%	-593.95%	-302.28%	-261.3%	-442.54%
Debt / Equity	-	2.48x	-	0.01x	0.01x	0.15x	0.21x
Interest Coverage	-	-	-	-	-	-62.12x	-39.79x
FCF Conversion	0.74x	0.91x	0.68x	0.94x	1.15x	0.82x	0.77x

Frequently Asked Questions

Growth & Financials

COMPASS Pathways plc (CMPS) grew revenue by 0.0% over the past year. Growth has been modest.

COMPASS Pathways plc (CMPS) reported a net loss of $237.3M for fiscal year 2024.

Dividend & Returns

COMPASS Pathways plc (CMPS) has a return on equity (ROE) of -81.5%. Negative ROE indicates the company is unprofitable.

COMPASS Pathways plc (CMPS) had negative free cash flow of $161.2M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener